Pharmaceutical manufacturer Adcock Ingram reported a 6% increase in total turnover, reaching R9.6 billion for the year ending in June. This growth was primarily driven by a rise in demand for the company’s winter products, as cold and flu cases and other respiratory illnesses surged. The company noted that it had increased its market share, maintaining its position as the…